WC
CELG

Whitnell & Co’s Celgene Corp CELG Stock Holding History

Whitnell & Co’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,100
Closed -$407K – 275
2019
Q3 		$407K Hold
4,100
– – 0.14% 115
2019
Q2 		$379K Hold
4,100
– – 0.14% 106
2019
Q1 		$387K Sell
4,100
-200
-5% -$17.5K 0.15% 109
2018
Q4 		$276K Buy
4,300
+1,100
+34% +$81.2K 0.12% 116
2018
Q3 		$286K Hold
3,200
– – 0.11% 115
2018
Q2 		$254K Sell
3,200
-175
-5% -$14.5K 0.11% 118
2018
Q1 		$301K Buy
3,375
+3,175
+1,588% +$305K 0.13% 111
2017
Q4 		$21K Hold
200
– – 0.01% 204
2017
Q3 		$29K Hold
200
– – 0.01% 194
2017
Q2 		$26K Hold
200
– – 0.01% 195
2017
Q1 		$25K Buy
+200
New +$23.9K 0.01% 201

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Whitnell & Co's CELG Position: Q4 2019 in Review

Whitnell & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,100 shares — an estimated $407K sold.

Whitnell & Co first reported a position in CELG in Q1 2017 and held it in 11 quarters. The position peaked at $407K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Whitnell & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Whitnell & Co sold 4,100 Celgene Corp shares in Q4 2019, an estimated $407K.
  • Whitnell & Co first reported a position in Celgene Corp in Q1 2017 and held it in 11 quarters.
  • Whitnell & Co's Celgene Corp position peaked at $407K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Whitnell & Co's 13F filing for Q4 2019, filed 11 Feb 2020.